LipimetiX Development Inc
Industry
- Biotechnology
- Large Molecule
- Drug Discovery Technologies
- ADMET
- Pharmaceuticals
Other Names/Subsidiaries
- LipimetiX, LLC
Latest on LipimetiX Development Inc
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in
Advantagene Closes $14.2m Series A Round Immuno-oncology firm Advantagene Inc. raised $14.2m through the sale of its Series A convertible preferred shares to undisclosed investors. National Securi
IN VITRO DIAGNOSTICS AltheaDx Inc. AltheaDx 's Series C brings in $30mm AltheaDx Inc. (oncology R&D services and personalized medicine focused on cardio, neuro, and blood disorders) brought in
Financings In the third quarter of 2012, start-up companies raised a total of $682 million across all industries, up roughly 19% from the previous quarter. ( See Exhibit 1. ) Of that money, $439.5 mil